A structure–antiarrhythmic activity relationship has been investigated using a chloroform model of arrhythmia in rats. A mathematical model capable of predicting and recognizing antiarrhythmic activity with 84% reliability is formulated. Optimization of the molecular design of lidocaine and procainamide, which have weak antiarrhythmic activity, has resulted in modeling and predicting 51 much more effective antiarrhythmic compounds that can be synthesized for further testing.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. A. Sysoeva, Treatment of Heart Rhythm Irregularities [in Russian], Ovetlei, Moscow (1993).
S. P. Golitsin, Klin. Farmakol. Ter., 6(3), 14 – 16 (1997).
R. P. Rakhmanov, Principles of Antiarrhythmic Therapy [in Russian], Anko, Moscow (2000).
A. V. Nedostup and O. V. Blagova, Rus. Med. Zh., 11(21), 1168 – 1172 (2003).
T. Szabo, L. Geller, B. Merkely, et al., Life Sci., 66(26), 2527 – 2541 (2000).
L. A. Tyurina, O. V. Tyurina, and A. M. Kolbin, Methods and Results of the Design and Prediction of Biologically Active Compounds [in Russian], Gilem, Ufa (2007).
C. Marot, P. Chavatte, and D. Lesieur, Quant. Struct.-Act. Relat., 19, 127 – 134 (2000).
H.-J. Kim, C. H. Chae, K. Y. Yi, et al., Bioorg. Med. Chem., 12(7), 1629 – 1641 (2004).
V. Poroikov and D. Filimonov, in: Rational Approaches to Drug Design, H.-D. Holtje and W. Sippl (eds.), Prous Science, Barcelona (2001), pp. 403 – 407.
S. Miyano, K. Sumoto, F. Satoh, et al., J. Med. Chem., 28, 714 – 717 (1985).
E. H. Banitt, J. R. Schmid, and R. Newmark, J. Med. Chem., 29, 299 – 302 (1986).
E. H. Banitt, W. E. Coyne, J. R. Schmid, and A. Mendel, J. Med. Chem., 18(11), 1130 – 1134 (1975).
P. A. Tenthorey, H. J. Adams, G. Kronberg, and B. H. Takman, J. Med. Chem., 24, 1059 – 1063 (1981).
P. A. Tenthorey, A. J. Block, R. A. Ronfeld, et al., J. Med. Chem., 24, 798 – 806 (1981).
R. E. Johnson, E. R. Baizman, C. Becker, et al., J. Med. Chem., 36, 3361 – 3370 (1993).
J. K. Campbell, R. T. Logan, R. J. Marshall, et al., J. Med. Chem., 29, 244 – 250 (1986).
E. W. Byrnes, P. D. McMaster, E. R. Smith, et al., J. Med. Chem., 22(10), 1171 – 1176 (1979).
I. Roufos, S. J. Hays, and D. J. Dooley, et al., J. Med. Chem., 37, 268 – 274 (1994).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 10, pp. 17 – 24, October, 2011.
Rights and permissions
About this article
Cite this article
Khairullina, V.R., Tarasov, G.P., Gerchikov, A.Y. et al. Modification of N 1-(2,6-dimethylphenyl)-N 2,N 2-diethylglycinamide and 4-amino-N[2-(diethylamino)ethyl]benzamide in order to increase their antiarrhythmic effect. Pharm Chem J 45, 597–604 (2012). https://doi.org/10.1007/s11094-012-0688-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-012-0688-1